Pycnogenol reduces the expression of P. aeruginosa T3SS and inflammatory response in NCI-H292 cells
Journal of Microbiology · 2025
DOI: 10.71150/jm.2503004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Microbiology, 2025. Verfasst von Seung-Ho Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Chungbuk 28116, Republic of Korea. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Flavonoids, Type III Secretion Systems, Anti-Bacterial Agents. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, Korea Research Institute of Bioscience and Biotechnology.
Abstract (Originalsprache)
Nosocomial infections caused by Pseudomonas aeruginosa (P. aeruginosa) have become increasingly common, particularly among immunocompromised individuals, who experience high mortality rates and prolonged treatment durations due to the limited availability of effective therapies. In this study, we screened for anti-ExoS compounds targeting P. aeruginosa and identified pycnogenol (PYC) as a potent inhibitor of the type III secretion system (T3SS), a major virulence mechanism responsible for the translocation of effectors such as ExoS. Using ELISA, western blotting, and real-time PCR analyses in both P. aeruginosa and infected H292 cells, we found that PYC significantly reduced T3SS activity. Mechanistically, PYC suppressed the transcription of T3SS-related genes by downregulating exsA expression in P. aeruginosa. Furthermore, pretreatment with PYC attenuated the cytotoxic effects and reduced the expression of proinflammatory cytokines, including interleukin-1β (IL-1β), interleukin-6 (IL-6), interleukin-8 (IL-8), and interleukin-18 (IL-18), in P. aeruginosa-infected H292 cells. These effects were associated with the inhibition of NF-κB signaling and inflammasome activation. Taken together, our findings suggest that PYC may serve as a promising therapeutic candidate against P. aeruginosa infections by targeting T3SS-mediated virulence and modulating host inflammatory responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Chungbuk 28116, Republic of Korea.
- College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Republic of Korea.
- ELEO Inc, Cheongju-si 28160, Republic of Korea.
- College of Pharmacy, Chungbuk National University, Chungbuk 28160, Republic of Korea.
- Department of Biotechnology and Bioinformatics, Korea university, Sejong 30019, Republic of Korea.
- Division of Practical Research, Honam National Institute of Biologucal Resources (HNIBR), Jeollanam-do 58762, Republic of Korea.
Förderung
- National Research Foundation of Korea
- Ministry of Science and ICT
- Korea Research Institute of Bioscience and Biotechnology
Zitieren
APA
Kim, S. H., Seo, D. Y., Han, S. B., Ha, U. H., Park, J. W., & Ahn, K. S. (2025). Pycnogenol reduces the expression of P. aeruginosa T3SS and inflammatory response in NCI-H292 cells. Journal of Microbiology. https://doi.org/10.71150/jm.2503004
Vancouver
Kim SH, Seo DY, Han SB, Ha UH, Park JW, Ahn KS. Pycnogenol reduces the expression of P. aeruginosa T3SS and inflammatory response in NCI-H292 cells. Journal of Microbiology. 2025. doi:10.71150/jm.2503004
BibTeX
@article{Kim2025,
author = {Kim, Seung-Ho and Seo, Da Yun and Han, Sang-Bae and Ha, Un-Hwan and Park, Ji-Won and Ahn, Kyung-Seop},
title = {Pycnogenol reduces the expression of P. aeruginosa T3SS and inflammatory response in NCI-H292 cells},
journal = {Journal of Microbiology},
year = {2025},
doi = {10.71150/jm.2503004}
}
EUVIMED